University of Melbourne and Sanofi Pasteur to develop human vaccines
22 January, 2014Sanofi Pasteur has signed a vaccine development agreement with the University of Melbourne. The alliance was facilitated by UoM Commercial, the university's commercial engagement services company.
Bioluminescence alliance receives ARC Linkage Grant
21 January, 2014A team of world leaders in the field of biomolecular interaction, relating to basic biomedical research and the discovery of new pharmaceuticals, has been the recipient of an Australian Research Council (ARC) Linkage Grant.
Federal funding to fight cancer and other diseases
21 January, 2014The federal government has awarded $8 million to three La Trobe University scientists for research into next-generation immunological and plant-based therapies for cancer and other diseases.
Lonza partners with Pharmacyclics to produce oncology drug
16 January, 2014Lonza, a supplier in chemical development and manufacturing, has established an agreement with Pharmacyclics to support the commercial and clinical production of its oral oncology drug Imbruvica (Ibrutinib).
TTP Labtech acquires fluorescence lifetime technology
13 January, 2014TTP Labtech has consolidated its position in the field of fluorescence lifetime (FLT) technology, having recently purchased assets from UK-based FLT company AssayMetrics.
IFCC certifies EKF Diagnostics point-of-care analyser
10 January, 2014Global diagnostics company EKF Diagnostics has announced that its Quo-Lab HbA1c point-of-care analyser has successfully achieved International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) certification.
3D electromaterials centre to be established
10 January, 2014The ARC Centre of Excellence for Electromaterials Science (ACES) has received $25 million to further develop work on smart nanomaterials by creating 3D devices with capabilities more advanced than those of their 2D counterparts.
US EPA contracts Stemina for toxicology tests
10 January, 2014Stemina Biomarker Discovery, a company whose cell-based tests combine stem cells and metabolomics, has been awarded a contract by the US Environmental Protection Agency (EPA) under its ToxCast initiative.
Continuous glucose monitoring market report released
20 December, 2013Allied Market Research (AMR) has released a market research report analysing current and future trends in the continuous glucose monitoring (CGM) market from 2012 to 2020. The report projects that the CGM market will reach $568.5 million by 2020 from its 2012 value of $194.8 million.
Grace granted Australian patent for flash chromatography technology
18 December, 2013WR Grace & Co has announced that the Australian Patent Office has granted a patent related to the company's Reveleris flash chromatography system. The patent concerns the use of evaporative light scattering detection (ELSD) with flash chromatography, which is a key component of the Reveleris flash chromatography system.
MYEFO allocates $103 million to research funding
18 December, 2013The Australian Government's Mid-year Economic and Fiscal Outlook (MYEFO), released yesterday, redirected $103 million to funding research which, according to Minister for Education Christopher Pyne, will help researchers deliver outcomes that will have significant benefit to the nation through the Australian Research Council (ARC).
So you've got a genius idea - now what?
13 December, 2013Intellectual assets can be commercialised but the road from idea to marketplace success can be fraught. Frequently those with the original genius idea are not by nature entrepreneurial or commercially savvy - this is especially true with those from a research or academic background and turning an intellectual asset into something tradable is not a simple, straightforward process.
Admedus acquires manufacturing facility from Genzyme Australasia
13 December, 2013Healthcare group Admedus (formerly Allied Healthcare) has signed a share purchase agreement to acquire an established manufacturing site from Genzyme Australasia, a Sanofi company. Admedus purchased the site to facilitate scaled-up production of its regenerative tissue product CardioCel.
Lorne conference season 2014
12 December, 2013The seaside town of Lorne, less than two hours' drive from Melbourne, will soon host its traditional series of life sciences conferences. The Mantra Lorne offers beachfront accommodation surrounded by 12 acres of landscaped gardens, making it an ideal setting for the two-week conference series.
Academy claims more science investment needed
03 December, 2013The Australian Academy of Science has presented a submission to the National Commission of Audit, arguing that Australia’s investment in science is moving backwards.
